119 related articles for article (PubMed ID: 16696885)
21. Unusual paratracheal masses presenting with vocal fold paralysis.
Reiter ER; Idowu MO; Powers CN
Ear Nose Throat J; 2006 Feb; 85(2):112-5. PubMed ID: 16579201
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-induced leukonychia.
Benatti C; Gnocchi M; Travaglino E; Invernizzi R; Ascari E
Haematologica; 2004 Jul; 89(7):EIM16. PubMed ID: 15257962
[No Abstract] [Full Text] [Related]
23. Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine: Case Report and Literature Review.
Aaron H; Azadarmaki R; Lango MN
Am J Ther; 2016; 23(2):e621-3. PubMed ID: 25738569
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Oncology Patients With Vincristine-Induced Recurrent Laryngeal Nerve Palsy: Two Case Reports and a Brief Review of Literature.
Tay SY; Foster J; Heczey A; Sitton M
Ear Nose Throat J; 2021 Dec; 100(10):NP459-NP463. PubMed ID: 32425060
[TBL] [Abstract][Full Text] [Related]
25. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
26. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
27. Vocal Fold Motion Impairment Following Chemotherapy Administration: Case Reports and Review of the Literature.
Talmor G; Nguyen B; Geller MT; Hsu J; Kaye R; Caloway C
Ann Otol Rhinol Laryngol; 2021 Apr; 130(4):405-415. PubMed ID: 33501843
[TBL] [Abstract][Full Text] [Related]
28. Progressive paresthesia and weakness after intrathecal chemotherapy.
Marshall R; Gupta ND; Palacios E; Neitzschman HR
J La State Med Soc; 2008; 160(2):92-4. PubMed ID: 18681351
[TBL] [Abstract][Full Text] [Related]
29. Regarding "Intrathecal vincristine: 3 fatal cases and a review of the literature".
Walter AW
J Pediatr Hematol Oncol; 2010 May; 32(4):336-7. PubMed ID: 20445422
[No Abstract] [Full Text] [Related]
30. Transient cortical blindness following vincristine therapy.
Schouten D; de Graaf SS; Verrips A
Med Pediatr Oncol; 2003 Nov; 41(5):470. PubMed ID: 14515391
[No Abstract] [Full Text] [Related]
31. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy.
Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F
Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662
[TBL] [Abstract][Full Text] [Related]
32. Vincristine-induced vocal cord palsy and successful re-treatment in a patient with diffuse large B cell lymphoma: a case report.
Samoon Z; Shabbir-Moosajee M
BMC Res Notes; 2014 May; 7():318. PubMed ID: 24886197
[TBL] [Abstract][Full Text] [Related]
33. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
[TBL] [Abstract][Full Text] [Related]
34. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
Krappmann P; Paulides M; Stöhr W; Ittner E; Plattig B; Nickel P; Lackner H; Schrappe M; Janka G; Beck JD; Langer T
Pediatr Hematol Oncol; 2007 Mar; 24(2):101-9. PubMed ID: 17454775
[TBL] [Abstract][Full Text] [Related]
35. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
36. Seizures as an adverse drug reaction after therapeutic dose of vincristine.
Mahapatra M; Kumar R; Choudhry VP
Ann Hematol; 2007 Feb; 86(2):153-4. PubMed ID: 17031686
[No Abstract] [Full Text] [Related]
37. Vincristine-induced recurrent laryngeal nerve paralysis in children.
Tobias JD; Bozeman PM
Intensive Care Med; 1991; 17(5):304-5. PubMed ID: 1939879
[TBL] [Abstract][Full Text] [Related]
38. Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
Boula AM; Mantadakis E; Xilouri IM; Christoforidou AV; Foudoulakis AM; Samonis G
Am J Hematol; 2005 Jul; 79(3):216-9. PubMed ID: 15981233
[TBL] [Abstract][Full Text] [Related]
39. Vincristine-induced laryngeal nerve paralysis.
Delaney P
Neurology; 1982 Nov; 32(11):1285-8. PubMed ID: 6957734
[TBL] [Abstract][Full Text] [Related]
40. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
Maciel JF; de Lourdes Chauffaille M; Inaoka RJ; Colleoni GW; Yamamoto M
Leuk Res; 2007 Nov; 31(11):1593-5. PubMed ID: 17324461
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
